{{Rsnum
|rsid=17624523
|Chromosome=2
|position=104542180
|Orientation=plus
|GMAF=0.1584
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 51.3 | 36.3 | 12.4
| HCB | 86.1 | 13.1 | 0.7
| JPT | 83.8 | 15.3 | 0.9
| YRI | 97.3 | 2.7 | 0.0
| ASW | 94.7 | 5.3 | 0.0
| CHB | 86.1 | 13.1 | 0.7
| CHD | 80.7 | 18.3 | 0.9
| GIH | 37.8 | 52.0 | 10.2
| LWK | 79.8 | 20.2 | 0.0
| MEX | 44.6 | 41.1 | 14.3
| MKK | 68.4 | 27.7 | 3.9
| TSI | 57.6 | 34.3 | 8.1
| HapMapRevision=28
}}{{PMID Auto GWAS
  |PMID=23006423
  |Trait=Response to taxane treatment (docetaxel)
  |Title=Genetic association with overall survival of taxane-treated lung cancer patients - A genome-wide association study in human lymphoblastoid cell lines followed by a clinical association study.
  |RiskAllele=
  |Pval=8E-6
  |OR=NR
  |ORtxt=NR
  |OA=1
}}

{{on chip | Affy GenomeWide 6}}
{{on chip | Illumina Human 1M}}